Clinical Trial Update: Safety and Immunogenicity of Locally Manufactured New (HL-OCV) Oral Cholera Vaccine [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial updating safety and immunogenicity data for a locally manufactured oral cholera vaccine (HL-OCV).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholera

Drugs mentioned

• HL-OCV

Snippet

Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh | Conditions: Cholera | Phase 1, Phase 2 | Status: COMPLETED